Tag: ISIS Pharmaceuticals Inc.

Health

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS): Analysts Maintain Consensus Target Of $41.70

Rebecca Harrison -
© Copyright 2018 - Financials Trend